Partner in the Litigation Group at Goodmans LLP. Practises commercial litigation, with an emphasis on intellectual property and technology disputes and licensing. Advises pharmaceutical clients regarding pricing strategy and regulatory issues. Has been counsel on a number of significant cases involving patent validity and infringement and on the leading cases involving the assessment and quantification of damages. Appears regularly before the Federal Court and Federal Court of Appeal. Editor-in-Chief of the Goodmans IP website, publishing IP articles daily. Lecturer in the "Intellectual Property in Health Law" course in the Professional LLM program at Osgoode Hall Law School. Frequent speaker and presenter on IP related topics. Completed a two-year laboratory study relating to Huntington’s disease at Massachusetts General Hospital (and Harvard Medical School) during his undergraduate studies. Recognized as a leading lawyer by Chambers Canada, The Legal 500 Canada, Who’s Who Legal: Life Sciences and Patent Litigation, WTR 1000, IAM Patent 1000, Best Lawyers in Canada, Lexpert, the Lexpert Special Editions: Technology and Health Sciences, and Litigation leading lawyers. Member of the Intellectual Property Institute of Canada, CTLA, and the Licensing Executives Society.